Hyperbaric Oxygen Therapy

Hyperbaric Oxygen Therapy (HBOT) has been demonstrated to be a safe and effective treatment for many different types of medical conditions. Medical science continues to learn about the various ways that HBOT can bring improvements to various medical diagnoses and physiological conditions.

Mild Hyperbaric Oxygen Therapy (mHBOT) has been bringing benefits to thousands of patients using a portable, soft-sided hyperbaric chamber that uses lower pressures that what has been traditionally used for HBOT, at oxygen levels less than 100%. Many people are eager to see if HBOT will be beneficial to themselves or someone in their family. We have developed a medical service where patients and families can receive in-home treatment with an FDA approved mHBOT Chamber via a rental program. The family can try this treatment for a month or two before deciding if they wish to purchase the equipment (the amount spent on the rental period is deducted from the sales price)

Please contact our office for more details about both in-home as well as in-office mHBOT therapy.

A patient of Dr. Berger’s with Autism was featured on Tampa CBS 10 News. The family described the progress that they have seen with mHBOT. The article can be viewed by clicking here HBOT NEWS

About Hyperbaric Therapy

Hyperbaric Oxygen Therapy (HBOT) is the breathing of oxygen at levels greater than which is found in room air, in an environment with increased pressure. Mild Hyperbaric Oxygen Therapy (mHBOT) utilizes a soft sided chamber, where the patient breathes less than 100% oxygen at a pressure of 1.3 atmospheres. This is the equivalent of diving down 8 feet under water.

Hyperbaric Oxygen Therapy is most known for its treatment of SCUBA divers who suffer from decompression sickness (the Bends). It is through this work that a session of HBOT became known as a “dive”.

The medical basis of HBOT is based on the laws of physics. “Henry’s Law” says that the amount of a gas dissolved in a liquid is in proportion to the pressure of the gas above the liquid, provided that no chemical action occurs. “Boyle’s Law” states that at a constant temperature, the volume and the pressure of a gas are inversely proportional. In other words, a gas will compress proportionately to the amount of pressure exerted on it. An example of these laws would be found in a sealed bottle of carbonated beverage. Until the bottle has been opened, the gas bubbles have dissolved in the fluid. Once the bottle has been opened, the pressure is released and the gas is no longer dissolved in the liquid (as seen by the formation of bubbles).

At room pressure, almost all oxygen that we breathe is transported in the red blood cells. When a patient is treated with Hyperbaric Oxygen Therapy, the oxygen is able to dissolve in the patient’s serum (the part of the bloodstream that is fluid, not blood cells). The end result of using HBOT is that more life-sustaining oxygen is delivered to the tissues and organs. In addition, due to the effects of HBOT, blood vessels are opened up, so more blood flows to these areas. This can bring more nutrients to the cells, and theoretically may facilitate greater removal of toxins that accumulate in the organs.

The FDA has approved HBOT for the following medical conditions: Air or Gas Embolism; Carbon Monoxide Poisoning and Smoke Inhalation; Carbon Monoxide Poisoning Complicated by Cyanide Poisoning; Clostridial Myonecrosis (Gas Gangrene); Crush Injury; Compartment Syndrome and other Acute Traumatic Ischemias; Decompression Sickness (the “Bends”); Enhancement of Healing in Selected Problem Wounds; Exceptional Blood Loss (Anemia); Necrotizing Soft Tissue Infections; Osteomyelitis (Refractory); Radiation Tissue Damage (Osteoradionecrosis); Skin Grafts and Flaps (Compromised); and Thermal Burns.

Medical Research has also shown that HBOT may be helpful for treating other conditions. These include (but are not limited to): Athletic Injuries; Autism; Autoimmune Diseases; Chemotherapy/Radiation Recovery; Skin Conditions; Hyperinflammatory Conditions; and Rheumatic Diseases. The FDA has not evaluated the use of HBOT for these conditions.